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Abstract 29 
Excitation-contraction (EC) coupling is the coordinated process by which an action potential 30 
triggers cardiac myocyte contraction. EC coupling is initiated in dyads where the junctional SR 31 
(jSR) is in tight proximity to the sarcolemma of cardiac myocytes. Existing models of EC 32 
coupling critically depend on dyad stability to ensure the fidelity and strength of EC coupling, 33 
where even small variations in RyR and CaV1.2 channel separation dramatically alters EC 34 
coupling. However, dyadic motility has never been studied. Here, we developed a novel strategy 35 
to track specific jSR units in dissociated adult ventricular myocytes using photo-activatable 36 
fluorescent proteins. We found that the jSR is not static. Instead, we observed dynamic 37 
formation and dissolution of multiple dyadic junctions regulated by the microtubule-associated 38 
molecular motors kinesin-1 and dynein. Our data support a model where reproducibility of EC 39 
coupling results from the activation of a temporally averaged number of SR Ca2+ release units 40 
forming and dissolving SR-sarcolemmal junctions. These findings challenge the long-held view 41 
that the jSR is an immobile structure and provide insights into the mechanisms underlying its 42 
motility. 43 
 44 
 45 
  46 
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Introduction 47 
Cardiac contractions are triggered by action potentials (AP). The chain of events that couple an 48 
AP to contraction is collectively known as excitation-contraction (EC) coupling. Multiple factors 49 
determine the strength of contraction, including Ca2+ influx, sarcoplasmic reticulum (SR) Ca2+ 50 
release, and the sensitivity of contractile proteins to cytosolic Ca2+.  51 
The coefficient of variation of the AP-evoked [Ca2+]i transient in an adult ventricular myocyte is 52 
about 0.1 (21), suggesting high EC coupling reproducibility. To understand mechanisms 53 
underlying [Ca2+]i transient reproducibility, it is pertinent to review key events during EC 54 
coupling. Activation of sarcolemmal CaV1.2 channels during the AP causes a small influx of 55 
Ca2+ that activates RyRs in the nearby jSR. The small distance and volume separating CaV1.2 56 
and RyR channels allows even brief openings of CaV1.2 channels to increase local [Ca2+]i high 57 
enough to activate nearby RyRs. Thus, the fidelity of local EC coupling critically depends on 58 
dyad structural stability and hence the separation between RyR and CaV1.2 channels.  59 
The jSR is a complex structure with several proteins contributing to its architecture and function. 60 
Junctophilin-2 (JPH2) is anchored to the jSR in its C-terminus and contacts the sarcolemma 61 
through lipid-interacting motifs in its N-terminus (7, 15). JPH2 is hypothesized to provide a 62 
molecular bridge between the jSR and the T-tubules (1, 19). The Ca2+-binding protein, 63 
calsequestrin is anchored to the jSR membrane by triadin (TRD) and junctin (23). TRD and 64 
junctin knockout mice show changes in jSR architecture (8, 23). This is important as even small 65 
changes in dyadic size and structure can perturb EC coupling by altering peak [Ca2+] levels and 66 
Ca2+ decay rates in the dyad (3, 9, 17). 67 
There is growing evidence that the dyad is not a stable structure; T-tubule – SR junctions show 68 
dynamic regulation, particularly during disease states (21). Multiple studies show that changes 69 
in T-tubule sarcolemma-SR junctions likely contribute to Ca2+ instability during pathology. In 70 
heart failure, physical uncoupling of the SR and T-tubules (23), T-tubule disorganization (11) 71 
and remodeled T-tubules moving away from Z-lines (18) underlie loss of local control and Ca2+ 72 
instability. Similarly, EC uncoupling and SR network fracturing occur during post-myocardial 73 
infarction (22). 74 
However, compared to T-tubule structural studies, jSR plasticity has received little attention. 75 
This can be attributed to the ease at which the T-tubule membrane can be visualized and the 76 
ineffectiveness of fluorescent labeling of the jSR (10, 21). In this study, we developed a novel 77 
strategy to monitor the stability of the T-tubule sarcolemma-SR junction in freshly isolated adult 78 
ventricular myocytes. Our data indicate that the jSR is a dynamic structure. This supports a 79 
novel paradigm shift that departs from the long-standing model of Ca2+ signaling modulated by a 80 
static dyad. The dynamic jSR creates another layer of Ca2+ signaling regulation; moreover, this 81 
regulation could exhibit exquisite local precision. 82 
Results 83 
Expression of TRD-paGFP allows the visualization of the jSR in ventricular myocytes. We 84 
designed two AAV9s for specific infection of adult ventricular myocytes: one to express TRD 85 
tagged with a photo-activatable GFP (AAV9-TRD-paGFP) and the other a constitutively 86 
fluorescent RFP-tag with a retention signal for the SR lumen (SR-RFP) (Figure 1A). TRD-87 
paGFP fluorescence is restricted to the set of proteins expressed at the time of photoactivation 88 
and is, therefore, proportional to the number of junctional proteins expressed and their relative 89 
position within the imaging focal plane. 90 
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Isolated ventricular myocytes expressing TRD-paGFP were exposed to the red-shifted 91 
potentiometric fluorescent indicator Di-8-ANNEPs (Di-8). Di-8 labeling identifies the sarcolemma 92 
and the T-tubular membrane in ventricular myocytes (Figure 1B). Upon photoactivation, we 93 
observed TRD-paGFP fluorescence in close proximity to Di-8 labeled T-tubules (Figure 1C). 94 
We analyzed the physical interaction of these signals by calculating a Pearson’s co-localization 95 
coefficient of 0.95 (C = 10, N = 5). In parallel experiments, myocytes expressing both TRD-96 
paGFP and SR-RFP were photoactivated to validate targeting of TRD-paGFP to the SR. As 97 
previously described (21), SR-RFP is broadly expressed in the lumen of the SR, showing that 98 
this organelle forms a vast network that extends throughout the cell. Upon photoactivation, 99 
TRD-paGFP fluorescence is observed at opposing ends of SR-expressing SR-RFP (Figure 100 
1D). Together, these data indicate that TRD-paGFP is expressed and properly targeted to the 101 
jSR of ventricular myocytes. 102 
The jSR has multiple modalities of mobility. To assess jSR mobility at T-tubules, we temporally 103 
measured and tracked TRD-paGFP and Di-8 signals after photoactivation. Confocal images 104 
were acquired in zero-drift compensation mode to ensure stable imaging of the same focal 105 
plane. Movie 1 (https://figshare.com/articles/Movie1_mp4/11396283) shows examples of stable 106 
and unstable jSR segments after photoactivation of TRD-paGFP. During analysis, we measured 107 
the averaged fluorescence intensity in 0.2 µm diameter ROIs within the area of the cell where 108 
TRD-paGFP was photoactivated. Whilst averaging TRD-paGFP intensity, we also determined 109 
the time course of Di-8 fluorescence in each of the sites where TRD-paGFP was activated. The 110 
coefficient of variation (COV = SD ÷ mean) of all Di-8 labeled sites analyzed had a normal, 111 
unimodal distribution (0.021 ± 0.008, C = 14, S = 132, N = 8) (Figure 2A). This suggests that T-112 
tubules are stable and that the focal plane did not change during the time course of imaging. In 113 
sharp contrast, analysis of TRD-paGFP fluorescent signal COV from these same sites reveals a 114 
larger degree of variation in intensities over time, both within and between cells. TRD-paGFP 115 
COVs demonstrate a multimodal distribution of fluorescent signals (Figure 2A). These 116 
distributions could be fit with the sum of four Gaussian functions with centers at 0.06, 0.16, and 117 
0.24 and 0.36 (Figure 2A). On the basis of this analysis, we classified jSR sites as “stable” and 118 
“unstable”. For a jSR to be considered “stable”, it must have a COV that is within the mean ± 3 119 
SDs (SD = 0.02) from the lowest TRD-paGFP COV average. Sites with a COV > 0.12, were 120 
considered to be “unstable” jSR sites. Figure 2B-G show representative time-courses of TRD-121 
paGFP and Di-8 signals from different imaging sites with variable COV values. In Figure 2B, 122 
TRD-paGFP and Di-8 fluorescence signals were stable throughout imaging. Indeed, the COV of 123 
this site was 0.06 and 0.07 for TRD-paGFP and Di-8, respectively. By contrast, Figure 2C-D, 124 
show two representative sites displaying TRD-paGFP COVs of 0.18 and 0.25. These relatively 125 
unstable sites showed frequent changes in TRD-paGFP, but not Di-8 fluorescence. Some sites 126 
demonstrated much greater COV values, suggesting a higher degree of jSR mobility (Figure 127 
2E-G). 128 
 129 
Because newly synthesized TRD does not fluoresce before activation with UV light, fluorescent 130 
intensity fluctuations likely represent changes in the localization of TRD-paGFP proteins 131 
previously activated in the experiment. For example, partial changes in TRD-paGFP 132 
fluorescence (<100%) likely reflect positional changes of the jSR within the focal plane. We 133 
speculate that complete loss and recovery of TRD-paGFP fluorescence is produced by the 134 
movement of the jSR in and out the focal plane. 135 
 136 
In addition to measuring jSR mobility, we discerned dwell times of jSR at T-tubules (i.e. time Di-137 
8 and TRD-paGFP fluorescent signals overlap). By default, stable TRD-paGFP/jSR sites had 138 
membrane dwell times > 15 minutes, or the duration of our experiments. The membrane dwell 139 
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times of unstable TRD-paGFP varied from 20-780 seconds, with an average of 257 ± 17.1 140 
seconds (C = 14, N = 8). 141 
We determined three distinct patterns of jSR biogenesis and motility. Figure 3B shows 142 
exemplary segments of jSR that 1) split to become two distinct segments, 2) retract or withdraw 143 
from the T-tubule, or 3) emerge to approach the T-tubule. Images in Figure 3A demonstrate a 144 
TRD-paGFP signal that split into two distinct segments. Split events represent the minority 145 
(15%) of jSR mobility, whereas jSR retraction (57%) and emergence (28%) encompass the 146 
majority of movement signatures. 147 
Dynein and kinesin-1 regulate jSR motility and decreases the variance and amplitude of the AP-148 
evoked [Ca2+]i transient. Work from our lab and others implicates the molecular motors dynein 149 
and kinesin-1 in SR/ER motility (14, 21). Dynein drives the processive movement of numerous 150 
intracellular cargos towards the minus end of microtubules (2). Kinesin-1 moves unidirectionally 151 
toward the plus end of microtubules (12). However, the role of these proteins in jSR mobility is 152 
unknown. We packaged motor-less kinesin-1 into viral vectors (AAV9-Kif5bDN-RFP) for live cell 153 
imaging. We also generated AAV9-Dnchc1-shRNA-RFP, which expresses an shRNA directed 154 
against Dnchc1, encoding dynein. We confirmed successful expression of these viruses by 155 
assaying for RFP fluorescence. Expression of this virus reduced dynein mRNA expression by 156 
62%. We found that myocytes expressing Kif5bDN-RFP (C = 8, S = 93, N = 5) the median 157 
(0.12) and range (0.65) of the COV values of jSR in these cells were lower than those from 158 
control myocytes (median = 0.69, range 1.77 ; C = 10, S = 166, N = 4) (Figure 4A). Similarly, 159 
Dnchc1-shRNA-RFP expressing myocytes had a lower median and smaller range of jSR COVs 160 
(median = 0.13, range = 0.48 ; C = 9, S = 100, N = 5) than myocytes expressing wild-type 161 
Dnchc1 (median = 0.72, range = 0.1.45; C = 9, S = 148, N = 5). These data suggest that dynein 162 
and kinesin-1 regulate jSR mobility in ventricular myocytes. 163 
Finally, we investigated the consequences of disrupting Kif5b expression on EC coupling. To do 164 
this, we loaded ventricular myocytes expressing Kif5B-WT and Kif5B-DN with the fluorescent 165 
Ca2+ indicator Fluo-4-AM and evoked whole-cell [Ca2+]i transients via field stimulation (1 Hz). 166 
During analysis, we aligned and averaged 20 successive [Ca2+]i transients. Figure 4B shows a 167 
representative averaged [Ca2+]i transient from Kif5B-WT (C = 7, N = 5) and Kif5b-DN (C = 6, N = 168 
4) expressing myocytes. Notably, expression of Kif5b-DN decreased the amplitude and the 169 
variance of AP-evoked [Ca2+]i in ventricular myocytes (Figure 4B). These data suggest that 170 
kinesin-1-dependent movement of the jSR contributes to the fidelity of the [Ca2+]i transients in 171 
ventricular myocytes to elicit EC coupling. 172 
Discussion 173 
This study is the first of its kind to visualize and characterize jSR movement in real time. We 174 
have made multiple novel observations relating to cardiac SR dynamics. First, the jSR is 175 
dynamic and moves in several modalities. Secondly, this bidirectional mobility is dependent on 176 
the molecular motors, kinesin-1 and dynein. Third, jSR mobility contributes to beat-to-beat 177 
variability of the AP-evoked [Ca2+]i in ventricular myocytes. These findings oppose the traditional 178 
dogma that the jSR is static to maximize the reproducibility of myocyte response to an AP. 179 
Instead, we see a complex system of potential regulation, where jSR segments locally move in 180 
and out of the T-tubules. Thus, whilst the reproducibility of the heartbeat under steady-state 181 
conditions is perpetuated by local SR Ca2+ release from a similar number of couplons in the 182 
myocyte, the spatial dwell time of many dyads could be transient. 183 
An intriguing observation in our study is that jSR mobility is multimodal. Interestingly, we find 184 
that retraction events are almost twice as common compared to emergence events. Yet, the 185 
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number of functional couplons activated during an AP does not change under steady-state 186 
conditions, implying that number of jSR emergence and retraction events should be matched 187 
(21). How can we reconcile these seemingly contradictory observations? We speculate that 188 
while we detected more retractions than emergence events, the average number of functional 189 
couplons remains the same under steady-state conditions because the retracting jSR could be 190 
replaced by new, non-fluorescent jSR. This could either be a result of a non-photoactivated 191 
TRD-paGFP (i.e., initially located outside the field of activation), or by a jSR that only expressed 192 
wild-type TRD. Alternatively, retracting jSR with a photoactivated TRD-paGFP could be moving 193 
to a different region of the cell, one that is outside the area being imaged. 194 
Several studies provide insights into the potential mechanisms underlying the mobility of the jSR 195 
and hence stability of the dyad. JPH2 is necessary for stabilizing the plasmalemma and jSR by 196 
providing a structural bridge between membranes. Cardiac-specific disruption of JPH2 197 
expression reduces the number of junctional membranes and increases dyadic size (20). JPH2 198 
can undergo Ca2+-dependent proteolysis under conditions of high [Ca2+]i in the dyad (13), 199 
compromising the coupling between the jSR and plasmalemma. In the context of our findings, 200 
we speculate that static jSR segments are stabilized by bound JPH2, whereas mobile jSR, 201 
rapidly moving in and out of T-tubules, lacks JPH2. Accordingly, jSR mobility could be related to 202 
the number of JPH2 in each dyad. 203 
A second determinant of jSR stability could be the lifetime of CaV1.2 channel clusters in the 204 
dyad. Cav1.2 clusters are formed by a stochastic self-assembly mechanism in the sarcolemma 205 
of ventricular myocytes (16). In developing cardiomyocytes, the nucleocytoplasmic adaptor 206 
protein, BIN1 serves as a delivery site for CaV1.2 channels, thereby facilitating the clustering of 207 
CaV1.2 channels (4). Furthermore, BIN1 serves as an anchor point for the jSR, promoting stable 208 
dyads and enhancing EC coupling (4). Thus, the formation of CaV1.2 clusters in the T-tubular 209 
membrane may be the first step in the formation of a functional dyad. Interestingly, the averaged 210 
membrane dwell time of mobile jSR that we measured here is similar to that of CaV1.2 channels 211 
(16). Thus, it is intriguing to hypothesize that all elements, including junctophilin, CaV1.2 212 
channels and BIN1, must be present for a functional, stable dyad to form and that the lifetime of 213 
a dyad may be coupled to the lifetime of the associated CaV1.2 cluster. Further investigations 214 
will be required to test this hypothesis. 215 
Another interesting finding in our study is that decreasing jSR mobility by downregulating Kif5b 216 
expression was associated with a decrease in the variance, but also a decrease in the 217 
amplitude of the [Ca2+]i transient. Thus, jSR mobility may be a determinant of beat-to-beat 218 
variability of the [Ca2+]i transient. At present however, the mechanisms by which loss of Kif5b 219 
decreases SR Ca2+ release are unclear and should be the subject of a future study.  220 
Finally, it is important to note that due to the diffraction-limited resolution of our microscope, we 221 
are unable to resolve jSR movement below approximately 250 nm in the lateral axis and 500-222 
600 nm in the axial axis. Therefore, our measurement for jSR mobility or jSR dwell times could 223 
be lower level estimates of dyad stability. 224 
In conclusion, our findings suggest a novel mechanism of EC coupling regulation. These studies 225 
suggest that jSR mobility may provide another layer of regulation for EC coupling. Future 226 
studies are necessary to define the precise extent of jSR mobility, investigate regulatory 227 
mechanisms and understand if jSR mobility is disrupted during pathology. 228 
 229 
 230 
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Methods 231 
Isolation of mouse ventricular myocytes. Male mice (C57BL/6J, 6-8 weeks old) were euthanized 232 
with a lethal dose of sodium pentobarbital administered intra-peritoneally as approved by the 233 
Institutional Animal Care and Use Committee. Ventricular myocytes were isolated using a 234 
Langendorff perfusion apparatus as previously described (5). The isolated ventricular myocytes 235 
were kept either at room temperature (22 °C) or at 37°C in Tyrode’s solution 0.5–5 h after 236 
isolation. 237 
Viral expression system. Mice were anesthetized by isoflurane and injected retro-orbitally with 238 
AAV9s encoding the following: TRD tagged with paGFP (AAV9-TRD-paGFP); a SR/ER 239 
retention signal tagged with RFP (AAV9-SR-RFP); an shRNA disruption expression of dynein 240 
tagged with RFP (AAV9-Dnchc1-shRNA-RFP); and a dominant-negative version of the kinesin-241 
1 tagged with RFP (AAV9-Kif5B-DN-RFP). To allow robust expression of fluorescent proteins 242 
and shRNA knockdown, experiments were performed at least three weeks after virus injection. 243 
jSR, T-tubule and [Ca2+]i imaging. To label jSR, paGFP was activated by brief illumination with 244 
405 nm light. To label T-tubules, di-8-ANEPPS was loaded into myocytes as previously 245 
described (6). To visualize and acquire paGFP and di-8-ANEPPS fluorescent signals, we used 246 
a laser-scanning Olympus FV1000 confocal microscope equipped with an Olympus 60x oil 247 
immersion lens. Images were acquired at 1Hz frequency with the Zero-Drift Compensation 248 
module engaged, continuously correcting for drifts and thus maintaining a stable focal plane 249 
throughout the duration of the experiment. For recordings of TRD-paGFP, each cell was 250 
scanned axially and recorded at a plane where the predominant number of TRDs could be seen 251 
and tracked. Myocytes were corrected for photobleaching using the Histogram Matching feature 252 
of Photo-correction in ImageJ. Cells were analyzed blind to experimental condition via name 253 
randomization. Whole-cell [Ca2+]i transients were measured in myocytes loaded with Fluo-4-AM. 254 
Statistics. Data are presented as COV or mean ± SEM. Two-sample comparisons of normally 255 
distributed data were made using a Student’s t test. A Kruskal-Wallis test was used to compare 256 
non-parametric data sets. ‘N’ represents number of mice used, ‘C’ and ‘S’ represent the number 257 
of cells and sites analyzed, respectively.  258 
 259 
 260 
 261 
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Figure Legends 333 
Figure 1: TRD-paGFP is expressed in the jSR of ventricular myocytes. A: illustration depicting 334 
the location of TRD-paGFP on the luminal aspect of the junctional SR (jSR). B: Di-8-ANNEPS 335 
labeling of the surface sarcolemma and T-tubules in an isolated ventricular myocyte. White box 336 
highlights a representative area where high power images are acquired. C: higher magnification 337 
imaging of the Di-8-ANNEPS labeled ventricular myocyte show labeled T-tubules. After local 338 
photoactivation (circular region) of TRD-paGFP with UV light, GFP fluorescence appears along 339 
the T-tubules, representing the location of the jSR. D: SR-RFP fluorescence is closely opposed 340 
to TRD-paGFP after photoactivation. 341 
Figure 2: The junctional SR is mobile at the cardiac dyad. A: histogram shows the frequency of 342 
T-tubule (TT) and jSR sites (S = 132) and their respective coefficient of variance (COV). TT 343 
sites show lower COV values indicating that they are static. jSR sites on the other hand are both 344 
static and mobile and can be fit by four Gaussian functions. The calculated threshold for a jSR 345 
to be mobile (static mean + 3 SDs) is noted on the histogram as a dotted line. B-D: fluorescent 346 
intensity plots (arbitrary units; A.U.) of TT fluorescence (red trace) and TRD-paGFP 347 
fluorescence (green trace) as a function of time. Blue lines at the beginning of each trace 348 
denotes period of photoactivation of TRD-paGFP. Each representative plot demonstrates 349 
individual jSR and TT tracking and fluorescent measurements with variable jSR COVs. 350 
Figure 3: The junctional SR displays different modalities for mobility. A: top, di-8-ANNEPS 351 
labeled T-tubules (TT) in a ventricular myocyte. White box indicates zoomed region. Middle, 352 
after photoactivation with UV light, TRD-paGFP fluorescence is localized to T-tubules. Bottom, 353 
during time-lapse imaging, TRD-paGFP fluorescence changes and TT fluorescence is static. B: 354 
representative images of jSR mobility. In the example retraction images, a region of TRD-355 
paGFP fluorescence disappears from the focal plane, whilst TT fluorescence in the same region 356 
remains. During emergence events, distinct regions within the focal plane increase in 357 
fluorescence over time. Split events represent the minority of jSR mobility and are characterized 358 
as an area of TRD fluorescence once a single unit is divided into two distinct regions over time. 359 
Figure 4: Dynein and kinesin-1 regulate jSR mobility. A: Scatter plot of the COV of individual 360 
jSR sites from cells expressing Dnchc1-shRNA (S = 100) or Kif5b-DN (S = 93) versus their 361 
respective WT controls (Kif5b-WT: S = 166; Dnchc1-WT: S = 148). Horizontal red lines in the 362 
plots mark the median and range of the data in each group. *P < 0.05; Kruskal-Wallis test. B: 363 
[Ca2+]i transients recorded from Fluo-4-AM loaded ventricular myocytes have a higher amplitude 364 
and variance in Kif5b-WT vs. Kif5B-DN myocytes. Data presented as mean ± SEM. *P < 0.05; 365 
Student’s unpaired t test. 366 
Movie 1: Movie showing a 3D spatiotemoral map of paGFP fluorescence in a ventricular 367 
myocyte before and after photoactivation with UV light. Time-lapse images show stable and 368 
unstable jSR segments.  369 
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